SPOTLIGHT: Novartis sues Trimeris for patent infringement
The biopharmaceutical company Trimeris says it's being sued by Novartis for infringing a patent the Swiss drug maker got a month ago. The suit targets Fuzeon, Trimeris' HIV treatment developed in collaboration with Roche and approved in 2003. Report
Be the first to comment
Comments
Post new comment
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets


